ArticleProceedings of the National Academy of Sciences of the United States of America2026
Lasker~Bloomberg Public Service Award to Michael J. Fox: The challenge of Parkinson's disease.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- QnAs with Michael J. Fox and Deborah W. Brooks.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This year's Lasker~Bloomberg Public Service Award honors the singular achievement of Michael J. Fox, who has devoted much of his life to a philanthropic effort to conquer Parkinson's Disease (PD), a progressive neurodegenerative disorder that afflicts many millions of patients world-wide. Just a few years after his diagnosis of PD at the tender age of 29, Fox pivoted in part from his enormous success in acting [leading roles in the Back to the Future trilogy (1985-1989) and in the hit National Broadcasting Corporation (NBC) sitcom Family Ties (1982-1989)] to the creation of the Michael J. Fox Foundation (MJFF). Fox's commitment and integrity have altered the landscape of inquiry into the clinical and basic science of PD and have helped to shape public policies and annually raise private ($400M) and government ($255M) support to find more effective treatments. In the 200 y since PD was first described, and despite recent decades of intense clinical work, only a few therapies have been developed to mitigate some aspects of the movement disorder. These treatments, especially the development of dopamine replacement and agonist drugs and the neurosurgical procedure of deep brain stimulation, have provided decades of limited symptom relief to millions of patients but no enduring therapies that alter the arc of progression of the disease. Now in the 4th decade of his personal battle with PD, Fox and the MJFF stand at the threshold of discoveries and clinical trials that show promise of therapies that go to the root causes of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.